Cinclus Pharma Holding AB (CINPHA) Price & Analysis

2 Followers

CINPHA Stock Chart & Stats

kr11.94

-kr0.32(-2.61%)

At close: Jul 24 4:00 PM EDT

kr11.94

-kr0.32(-2.61%)

Day’s Range― - ―

52-Week Rangekr10.48 - kr19.64

Previous CloseN/A

Volume4.96K

Average Volume (3M)55.07K

Market Cap

kr586.38M

Enterprise Valuekr178.67

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.10

Next Earnings

Nov 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.69

Shares Outstanding46,537,790

10 Day Avg. Volume32,670

30 Day Avg. Volume55,072

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-1.68

Revenue Forecast (FY)kr104.00M

Cinclus Pharma Holding AB News

Cinclus Pharma Completes Patient Visits in Pivotal Phase III GERD Trial

Cinclus Pharma Holding AB ( ($SE:CINPHA) ) just unveiled an announcement. Cinclus Pharma has completed all planned patient...

2d ago

Cinclus Pharma Clears Key Phase III Milestone in Erosive GERD Trial

Cinclus Pharma Holding AB ( ($SE:CINPHA) ) has shared an announcement. Cinclus Pharma has completed the eight-week treatment...

29d ago

Cinclus Pharma Details 2026 Interim Progress and Market Focus

Cinclus Pharma Holding AB ( ($SE:CINPHA) ) has issued an announcement. Cinclus Pharma Holding AB released its interim...

1M ago

Cinclus Pharma sets August 19 date for Q2 2026 results presentation

Cinclus Pharma Holding AB ( ($SE:CINPHA) ) has shared an announcement. Cinclus Pharma will publish its second-quarter report...

2M ago

Cinclus Pharma Hits Phase III Enrollment Milestone in Severe GERD Trial

Cinclus Pharma Holding AB ( ($SE:CINPHA) ) just unveiled an announcement. Cinclus Pharma has reached its randomization target...

3M ago

Cinclus Pharma Advances Linaprazan Glurate Heart‑Safety Study, Keeping GERD Pipeline on Track

Cinclus Pharma Holding AB ($SE:CINPHA) announced an update on their ongoing clinical study. The Phase I trial “A...

4M ago

Cinclus Pharma Hits Phase III Milestone in Erosive GERD Trial

Cinclus Pharma Holding AB ( ($SE:CINPHA) ) has provided an update. Cinclus Pharma has reached a key Phase...

4M ago

Cinclus Pharma Withdraws Key Phase 3 GERD Trial, Resetting Expectations for Linaprazan Glurate

Cinclus Pharma Holding AB ($SE:CINPHA) announced an update on their ongoing clinical study. Cinclus Pharma Holding AB (CINPHA)...

4M ago

Cinclus Pharma AGM backs new share mandate and long-term incentive plan

Cinclus Pharma Holding AB ( ($SE:CINPHA) ) just unveiled an announcement. Cinclus Pharma Holding AB’s annual general meeting...

4M ago

Cinclus Pharma Publishes Q1 2026 Interim Report Highlighting Late-Stage Pipeline and Market Potential

An update from Cinclus Pharma Holding AB ( ($SE:CINPHA) ) is now available. Cinclus Pharma Holding AB has...

5M ago

CINPHA FAQ

What was Cinclus Pharma Holding AB’s price range in the past 12 months?

Cinclus Pharma Holding AB lowest stock price was kr10.48 and its highest was kr19.64 in the past 12 months.

What is Cinclus Pharma Holding AB’s market cap?

Cinclus Pharma Holding AB’s market cap is kr586.38M.

When is Cinclus Pharma Holding AB’s upcoming earnings report date?

Cinclus Pharma Holding AB’s upcoming earnings report date is Nov 11, 2026 which is in 41 days.

How were Cinclus Pharma Holding AB’s earnings last quarter?

Cinclus Pharma Holding AB released its earnings results on Aug 19, 2026. The company reported -kr1.692 earnings per share for the quarter.

Is Cinclus Pharma Holding AB overvalued?

According to Wall Street analysts Cinclus Pharma Holding AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cinclus Pharma Holding AB pay dividends?

Cinclus Pharma Holding AB does not currently pay dividends.

What is Cinclus Pharma Holding AB’s EPS estimate?

Cinclus Pharma Holding AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cinclus Pharma Holding AB have?

Cinclus Pharma Holding AB has 46,537,790 shares outstanding.

What happened to Cinclus Pharma Holding AB’s price movement after its last earnings report?

Cinclus Pharma Holding AB reported an EPS of -kr1.692 in its last earnings report. Following the earnings report the stock price went up 3.125%.

Which hedge fund is a major shareholder of Cinclus Pharma Holding AB?

Currently, no hedge funds are holding shares in SE:CINPHA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology